Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Ignis Asset Management was a prominent UK-based asset management firm headquartered in Glasgow, Scotland. It operated as the investment management arm of the Phoenix Group before being acquired by Standard Life Investments in 2014. The firm managed a wide range of investment products, including fixed income, equities, and real estate, for both institutional and retail clients. At the time of its acquisition, it managed approximately £59 billion in assets. Following the deal, its operations and personnel were integrated into Standard Life, which later became part of abrdn. The company is distinct from biotech entities with similar names, such as Ignis Therapeutics.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Ignis Asset Management.